

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.68300821 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.68300821 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.34636817 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.34636817 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.94458566 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.29468072 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.29468072 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.29468072 |
| 9 | bile acid biosynthetic process (GO:0006699) | 5.21870016 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.20608436 |
| 11 | regulation of protein activation cascade (GO:2000257) | 5.12116489 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.11557097 |
| 13 | tryptophan metabolic process (GO:0006568) | 4.99740140 |
| 14 | complement activation, alternative pathway (GO:0006957) | 4.98642480 |
| 15 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.95932212 |
| 16 | protein carboxylation (GO:0018214) | 4.95932212 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 4.94234875 |
| 18 | regulation of complement activation (GO:0030449) | 4.87376511 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.84822473 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.81525975 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.81042149 |
| 22 | urea cycle (GO:0000050) | 4.74744047 |
| 23 | urea metabolic process (GO:0019627) | 4.74744047 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.67128577 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.58554946 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.46778785 |
| 27 | cysteine metabolic process (GO:0006534) | 4.40536222 |
| 28 | bile acid metabolic process (GO:0008206) | 4.40375397 |
| 29 | coenzyme catabolic process (GO:0009109) | 4.36639384 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.33349344 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.32964982 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.32611349 |
| 33 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.23602579 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.22710309 |
| 35 | tyrosine metabolic process (GO:0006570) | 4.18523526 |
| 36 | lysine metabolic process (GO:0006553) | 4.14963724 |
| 37 | lysine catabolic process (GO:0006554) | 4.14963724 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 4.11150745 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.08781365 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.08781365 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.08781365 |
| 42 | negative regulation of protein activation cascade (GO:2000258) | 4.04732745 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 3.99078123 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 3.98095675 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 3.89059934 |
| 46 | phospholipid efflux (GO:0033700) | 3.88164284 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 3.85478579 |
| 48 | acylglycerol homeostasis (GO:0055090) | 3.84380143 |
| 49 | triglyceride homeostasis (GO:0070328) | 3.84380143 |
| 50 | cellular modified amino acid catabolic process (GO:0042219) | 3.82434256 |
| 51 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.81967898 |
| 52 | bile acid and bile salt transport (GO:0015721) | 3.81310181 |
| 53 | cellular amino acid catabolic process (GO:0009063) | 3.72233509 |
| 54 | cholesterol efflux (GO:0033344) | 3.71204722 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 3.67408090 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 3.67316126 |
| 57 | fibrinolysis (GO:0042730) | 3.67295883 |
| 58 | cellular ketone body metabolic process (GO:0046950) | 3.66562426 |
| 59 | amine catabolic process (GO:0009310) | 3.63189001 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 3.63189001 |
| 61 | glutamate metabolic process (GO:0006536) | 3.60427188 |
| 62 | low-density lipoprotein particle remodeling (GO:0034374) | 3.59651981 |
| 63 | benzene-containing compound metabolic process (GO:0042537) | 3.53742691 |
| 64 | cellular glucuronidation (GO:0052695) | 3.49867311 |
| 65 | negative regulation of sterol transport (GO:0032372) | 3.49438112 |
| 66 | negative regulation of cholesterol transport (GO:0032375) | 3.49438112 |
| 67 | phospholipid homeostasis (GO:0055091) | 3.49100501 |
| 68 | acetyl-CoA metabolic process (GO:0006084) | 3.47886729 |
| 69 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.46016458 |
| 70 | cofactor catabolic process (GO:0051187) | 3.42924552 |
| 71 | negative regulation of complement activation (GO:0045916) | 3.42173089 |
| 72 | paraxial mesoderm development (GO:0048339) | 3.38978361 |
| 73 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.38773555 |
| 74 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.38720876 |
| 75 | complement activation, classical pathway (GO:0006958) | 3.38526291 |
| 76 | positive regulation of lipid catabolic process (GO:0050996) | 3.38315025 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 3.36521161 |
| 78 | complement activation (GO:0006956) | 3.36007786 |
| 79 | morphogenesis of an epithelial sheet (GO:0002011) | 3.33108988 |
| 80 | arginine metabolic process (GO:0006525) | 3.32289846 |
| 81 | carboxylic acid catabolic process (GO:0046395) | 3.29195414 |
| 82 | organic acid catabolic process (GO:0016054) | 3.29195414 |
| 83 | plasma lipoprotein particle assembly (GO:0034377) | 3.28681053 |
| 84 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.27143172 |
| 85 | protein activation cascade (GO:0072376) | 3.25671018 |
| 86 | drug catabolic process (GO:0042737) | 3.25234483 |
| 87 | ethanol oxidation (GO:0006069) | 3.24335775 |
| 88 | midgut development (GO:0007494) | 3.24235876 |
| 89 | short-chain fatty acid metabolic process (GO:0046459) | 3.23951570 |
| 90 | presynaptic membrane assembly (GO:0097105) | 3.23913707 |
| 91 | intestinal cholesterol absorption (GO:0030299) | 3.23713532 |
| 92 | regulation of cholesterol metabolic process (GO:0090181) | 3.21655894 |
| 93 | regulation of cholesterol homeostasis (GO:2000188) | 3.21570698 |
| 94 | fatty acid beta-oxidation (GO:0006635) | 3.20013453 |
| 95 | cytolysis (GO:0019835) | 3.18499371 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.17786753 |
| 97 | opsonization (GO:0008228) | 3.16155799 |
| 98 | ketone body metabolic process (GO:1902224) | 3.14168846 |
| 99 | fatty acid oxidation (GO:0019395) | 3.13514233 |
| 100 | monocarboxylic acid catabolic process (GO:0072329) | 3.13375056 |
| 101 | cholesterol homeostasis (GO:0042632) | 3.12875558 |
| 102 | aspartate family amino acid catabolic process (GO:0009068) | 3.11981953 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.11800311 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.11800311 |
| 105 | glycine metabolic process (GO:0006544) | 3.11380752 |
| 106 | regulation of relaxation of muscle (GO:1901077) | 3.11373919 |
| 107 | lipid oxidation (GO:0034440) | 3.10089304 |
| 108 | plasma lipoprotein particle organization (GO:0071827) | 3.10035824 |
| 109 | notochord development (GO:0030903) | 3.08676924 |
| 110 | regulation of cell communication by electrical coupling (GO:0010649) | 3.04304631 |
| 111 | embryonic foregut morphogenesis (GO:0048617) | 3.04263804 |
| 112 | Notch signaling involved in heart development (GO:0061314) | 3.02976931 |
| 113 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.01461515 |
| 114 | lymphangiogenesis (GO:0001946) | 2.90647483 |
| 115 | heart valve formation (GO:0003188) | 2.90111119 |
| 116 | presynaptic membrane organization (GO:0097090) | 2.89982340 |
| 117 | regulation of cardioblast differentiation (GO:0051890) | 2.89012585 |
| 118 | negative regulation of vascular permeability (GO:0043116) | 2.88693836 |
| 119 | endocardial cushion morphogenesis (GO:0003203) | 2.85363263 |
| 120 | apical protein localization (GO:0045176) | 2.83704694 |
| 121 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.82530719 |
| 122 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.80228291 |
| 123 | cGMP-mediated signaling (GO:0019934) | 2.79969782 |
| 124 | dorsal/ventral axis specification (GO:0009950) | 2.73849359 |
| 125 | positive regulation of vascular permeability (GO:0043117) | 2.71072799 |
| 126 | endothelium development (GO:0003158) | 2.69213463 |
| 127 | cell communication by electrical coupling (GO:0010644) | 2.68973400 |
| 128 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.67316319 |
| 129 | surfactant homeostasis (GO:0043129) | 2.65569443 |
| 130 | establishment of nucleus localization (GO:0040023) | 2.65108610 |
| 131 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.64771646 |
| 132 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.64123438 |
| 133 | mesenchyme morphogenesis (GO:0072132) | 2.63343035 |
| 134 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.63180239 |
| 135 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.58879851 |
| 136 | lymph vessel development (GO:0001945) | 2.58470087 |
| 137 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.55148870 |
| 138 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.52987249 |
| 139 | membrane assembly (GO:0071709) | 2.51921483 |
| 140 | astrocyte development (GO:0014002) | 2.51905017 |
| 141 | cardiac myofibril assembly (GO:0055003) | 2.50528595 |
| 142 | chemical homeostasis within a tissue (GO:0048875) | 2.48572891 |
| 143 | regulation of axon guidance (GO:1902667) | 2.48140924 |
| 144 | hippo signaling (GO:0035329) | 2.45804621 |
| 145 | coronary vasculature morphogenesis (GO:0060977) | 2.45020856 |
| 146 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.44351113 |
| 147 | postsynaptic membrane organization (GO:0001941) | 2.42366953 |
| 148 | cardiac epithelial to mesenchymal transition (GO:0060317) | 2.42065538 |
| 149 | asymmetric protein localization (GO:0008105) | 2.41915952 |
| 150 | myelination in peripheral nervous system (GO:0022011) | 2.41818277 |
| 151 | peripheral nervous system axon ensheathment (GO:0032292) | 2.41818277 |
| 152 | positive regulation of p38MAPK cascade (GO:1900745) | 2.41633177 |
| 153 | polarized epithelial cell differentiation (GO:0030859) | 2.41583116 |
| 154 | regulation of vasculogenesis (GO:2001212) | 2.39211004 |
| 155 | regulation of actin filament-based movement (GO:1903115) | 2.35962864 |
| 156 | establishment of apical/basal cell polarity (GO:0035089) | 2.35537487 |
| 157 | neuromuscular junction development (GO:0007528) | 2.35197421 |
| 158 | pericardium development (GO:0060039) | 2.35017147 |
| 159 | endothelial cell differentiation (GO:0045446) | 2.33230540 |
| 160 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.32561583 |
| 161 | positive regulation of vasculogenesis (GO:2001214) | 2.28782611 |
| 162 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.28276202 |
| 163 | atrial cardiac muscle cell action potential (GO:0086014) | 2.27502683 |
| 164 | neuron recognition (GO:0008038) | 2.26991818 |
| 165 | regulation of vascular permeability (GO:0043114) | 2.26361210 |
| 166 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.26267760 |
| 167 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.26130859 |
| 168 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.25827831 |
| 169 | cell migration involved in gastrulation (GO:0042074) | 2.24596334 |
| 170 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 2.23502481 |
| 171 | axon ensheathment in central nervous system (GO:0032291) | 2.22800008 |
| 172 | central nervous system myelination (GO:0022010) | 2.22800008 |
| 173 | SMAD protein signal transduction (GO:0060395) | 2.22620739 |
| 174 | axonal fasciculation (GO:0007413) | 2.22137939 |
| 175 | cellular sodium ion homeostasis (GO:0006883) | 2.21134930 |
| 176 | ectodermal placode formation (GO:0060788) | 2.19800780 |
| 177 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.18089827 |
| 178 | vasculogenesis (GO:0001570) | 2.17436935 |
| 179 | nucleus localization (GO:0051647) | 2.16106309 |
| 180 | negative regulation of hormone metabolic process (GO:0032351) | 2.16040071 |
| 181 | gastrulation with mouth forming second (GO:0001702) | 2.15673329 |
| 182 | artery development (GO:0060840) | 2.15040738 |
| 183 | lateral sprouting from an epithelium (GO:0060601) | 2.13488542 |
| 184 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.12422675 |
| 185 | blood vessel morphogenesis (GO:0048514) | 2.11997267 |
| 186 | anterior/posterior axis specification, embryo (GO:0008595) | 2.11941750 |
| 187 | cellular response to cholesterol (GO:0071397) | 2.11757314 |
| 188 | heart morphogenesis (GO:0003007) | 2.11516395 |
| 189 | positive regulation of astrocyte differentiation (GO:0048711) | 2.11296884 |
| 190 | establishment of monopolar cell polarity (GO:0061162) | 2.11169331 |
| 191 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.11169331 |
| 192 | cardiac muscle hypertrophy (GO:0003300) | 2.11070254 |
| 193 | glomerular visceral epithelial cell development (GO:0072015) | 2.10010447 |
| 194 | otic vesicle formation (GO:0030916) | 2.08911238 |
| 195 | positive regulation of muscle hypertrophy (GO:0014742) | 2.08497693 |
| 196 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.08497693 |
| 197 | layer formation in cerebral cortex (GO:0021819) | 2.07763999 |
| 198 | regulation of p38MAPK cascade (GO:1900744) | 2.07482264 |
| 199 | cellular response to BMP stimulus (GO:0071773) | 2.06792011 |
| 200 | response to BMP (GO:0071772) | 2.06792011 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.37542534 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.01256970 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.94943667 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.88539216 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.63206246 |
| 6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.85666052 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63432043 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.57333978 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.11993280 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.47629481 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.17592667 |
| 12 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.15142130 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.90338167 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.72278169 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70783089 |
| 16 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.70740513 |
| 17 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.69559513 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.66675175 |
| 19 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.62163904 |
| 20 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61863337 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59413021 |
| 22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.58109149 |
| 23 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.56731755 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.56356621 |
| 25 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54528105 |
| 26 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.52188000 |
| 27 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.51777891 |
| 28 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.51698721 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.48999160 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47575302 |
| 31 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46602544 |
| 32 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.44597550 |
| 33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44135038 |
| 34 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43451318 |
| 35 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.43348176 |
| 36 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.42645838 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42632333 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.42196329 |
| 39 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41162524 |
| 40 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41162524 |
| 41 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40165935 |
| 42 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.39302278 |
| 43 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39096518 |
| 44 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.38212105 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37658906 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.36904751 |
| 47 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.36412921 |
| 48 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.35741119 |
| 49 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35673647 |
| 50 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35480921 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33304962 |
| 52 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.27284047 |
| 53 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.26682505 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25757568 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24189595 |
| 56 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24167174 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.23689106 |
| 58 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23091525 |
| 59 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.22188425 |
| 60 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.21998047 |
| 61 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.21983622 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20721469 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20206319 |
| 64 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.19935354 |
| 65 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18669493 |
| 66 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.17922971 |
| 67 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.17865283 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17810902 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17573167 |
| 70 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.16502274 |
| 71 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.16434014 |
| 72 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.16273238 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16154092 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.15901077 |
| 75 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15219135 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14002308 |
| 77 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13847232 |
| 78 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13679612 |
| 79 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11830478 |
| 80 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09895896 |
| 81 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.09515132 |
| 82 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.09221066 |
| 83 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08124300 |
| 84 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.08076041 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.07836410 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07404303 |
| 87 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.06593254 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.03788127 |
| 89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03610927 |
| 90 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.03342671 |
| 91 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03267116 |
| 92 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02643526 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.02545645 |
| 94 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01978366 |
| 95 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.00810682 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00546663 |
| 97 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97126273 |
| 98 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96850931 |
| 99 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95967225 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95412092 |
| 101 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.94878292 |
| 102 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94402552 |
| 103 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92362554 |
| 104 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.90975910 |
| 105 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87939572 |
| 106 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.84642655 |
| 107 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84320193 |
| 108 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.84202935 |
| 109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.84121801 |
| 110 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83935488 |
| 111 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.83081333 |
| 112 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83003566 |
| 113 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81822841 |
| 114 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81649901 |
| 115 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.81420603 |
| 116 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.80843051 |
| 117 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.80603442 |
| 118 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.80603442 |
| 119 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.80380038 |
| 120 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.79188852 |
| 121 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.78285327 |
| 122 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.78265221 |
| 123 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.77761966 |
| 124 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.77741541 |
| 125 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77493767 |
| 126 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77429828 |
| 127 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.76177974 |
| 128 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.75437182 |
| 129 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.75193977 |
| 130 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.74971454 |
| 131 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73885715 |
| 132 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.73366349 |
| 133 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72871258 |
| 134 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72812765 |
| 135 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.72362174 |
| 136 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.71586814 |
| 137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.70698872 |
| 138 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.70458310 |
| 139 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.70435146 |
| 140 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.70408809 |
| 141 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70317198 |
| 142 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69292713 |
| 143 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.69292387 |
| 144 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.68589608 |
| 145 | STAT3_23295773_ChIP-Seq_U87_Human | 0.68034914 |
| 146 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.67826054 |
| 147 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67753289 |
| 148 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.67210454 |
| 149 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.66714680 |
| 150 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.66709289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.20909229 |
| 2 | MP0005360_urolithiasis | 6.33229003 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.79162507 |
| 4 | MP0005365_abnormal_bile_salt | 5.49463206 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.06913095 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.92761486 |
| 7 | MP0003252_abnormal_bile_duct | 3.67702494 |
| 8 | MP0005083_abnormal_biliary_tract | 3.48759042 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.06328696 |
| 10 | MP0003195_calcinosis | 2.82380727 |
| 11 | MP0005332_abnormal_amino_acid | 2.59279969 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.50685932 |
| 13 | MP0003941_abnormal_skin_development | 2.41439671 |
| 14 | MP0001879_abnormal_lymphatic_vessel | 2.37868226 |
| 15 | MP0000537_abnormal_urethra_morphology | 2.34413898 |
| 16 | MP0009840_abnormal_foam_cell | 2.15295758 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 1.95559582 |
| 18 | MP0000778_abnormal_nervous_system | 1.91566319 |
| 19 | MP0003890_abnormal_embryonic-extraembry | 1.88253223 |
| 20 | MP0003868_abnormal_feces_composition | 1.86832089 |
| 21 | MP0003136_yellow_coat_color | 1.85529369 |
| 22 | MP0003385_abnormal_body_wall | 1.84161898 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.83629553 |
| 24 | MP0009697_abnormal_copulation | 1.83531279 |
| 25 | MP0005623_abnormal_meninges_morphology | 1.81226010 |
| 26 | MP0004272_abnormal_basement_membrane | 1.79595011 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 1.77133505 |
| 28 | MP0000609_abnormal_liver_physiology | 1.74810067 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.74768449 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 1.73557172 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.66161221 |
| 32 | MP0005187_abnormal_penis_morphology | 1.61369893 |
| 33 | MP0001958_emphysema | 1.58794056 |
| 34 | MP0000534_abnormal_ureter_morphology | 1.57914196 |
| 35 | MP0003937_abnormal_limbs/digits/tail_de | 1.55252304 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.54873360 |
| 37 | MP0006138_congestive_heart_failure | 1.53924163 |
| 38 | MP0002697_abnormal_eye_size | 1.53161335 |
| 39 | MP0000751_myopathy | 1.51603836 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.48957312 |
| 41 | MP0010030_abnormal_orbit_morphology | 1.48892291 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 1.48264622 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.47836148 |
| 44 | MP0004084_abnormal_cardiac_muscle | 1.44643947 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.43000316 |
| 46 | MP0002254_reproductive_system_inflammat | 1.42677999 |
| 47 | MP0010368_abnormal_lymphatic_system | 1.40059949 |
| 48 | MP0000013_abnormal_adipose_tissue | 1.36164319 |
| 49 | MP0003935_abnormal_craniofacial_develop | 1.32546885 |
| 50 | MP0000462_abnormal_digestive_system | 1.29734036 |
| 51 | MP0004215_abnormal_myocardial_fiber | 1.27738885 |
| 52 | MP0003950_abnormal_plasma_membrane | 1.26632886 |
| 53 | MP0003119_abnormal_digestive_system | 1.26365826 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.26124374 |
| 55 | MP0000428_abnormal_craniofacial_morphol | 1.25583522 |
| 56 | MP0005171_absent_coat_pigmentation | 1.24667006 |
| 57 | MP0002638_abnormal_pupillary_reflex | 1.18597205 |
| 58 | MP0009250_abnormal_appendicular_skeleto | 1.16319296 |
| 59 | MP0001764_abnormal_homeostasis | 1.15312443 |
| 60 | MP0002233_abnormal_nose_morphology | 1.15288489 |
| 61 | MP0006054_spinal_hemorrhage | 1.14405265 |
| 62 | MP0002009_preneoplasia | 1.12336194 |
| 63 | MP0002084_abnormal_developmental_patter | 1.11136496 |
| 64 | MP0001486_abnormal_startle_reflex | 1.10870288 |
| 65 | MP0000604_amyloidosis | 1.10320986 |
| 66 | MP0009643_abnormal_urine_homeostasis | 1.09951364 |
| 67 | MP0004858_abnormal_nervous_system | 1.05971163 |
| 68 | MP0000733_abnormal_muscle_development | 1.05855163 |
| 69 | MP0000762_abnormal_tongue_morphology | 1.05153152 |
| 70 | MP0005409_darkened_coat_color | 1.04700900 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 1.02253139 |
| 72 | MP0003115_abnormal_respiratory_system | 1.00977555 |
| 73 | MP0001984_abnormal_olfaction | 0.99870443 |
| 74 | MP0005595_abnormal_vascular_smooth | 0.99029064 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 0.98760254 |
| 76 | MP0003011_delayed_dark_adaptation | 0.98636701 |
| 77 | MP0003091_abnormal_cell_migration | 0.98197723 |
| 78 | MP0001661_extended_life_span | 0.98049509 |
| 79 | MP0002925_abnormal_cardiovascular_devel | 0.97898416 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.97723459 |
| 81 | MP0010630_abnormal_cardiac_muscle | 0.97339478 |
| 82 | MP0004036_abnormal_muscle_relaxation | 0.96881465 |
| 83 | MP0001915_intracranial_hemorrhage | 0.95493499 |
| 84 | MP0008438_abnormal_cutaneous_collagen | 0.93757967 |
| 85 | MP0004130_abnormal_muscle_cell | 0.93405979 |
| 86 | * MP0003634_abnormal_glial_cell | 0.93156808 |
| 87 | MP0004087_abnormal_muscle_fiber | 0.93067517 |
| 88 | * MP0000955_abnormal_spinal_cord | 0.93063048 |
| 89 | MP0000003_abnormal_adipose_tissue | 0.91892689 |
| 90 | MP0000598_abnormal_liver_morphology | 0.91771173 |
| 91 | MP0005647_abnormal_sex_gland | 0.91139329 |
| 92 | MP0009384_cardiac_valve_regurgitation | 0.90986483 |
| 93 | MP0002928_abnormal_bile_duct | 0.90776215 |
| 94 | MP0002088_abnormal_embryonic_growth/wei | 0.90329441 |
| 95 | MP0002184_abnormal_innervation | 0.89735420 |
| 96 | MP0003984_embryonic_growth_retardation | 0.89033059 |
| 97 | MP0009053_abnormal_anal_canal | 0.88455954 |
| 98 | MP0003880_abnormal_central_pattern | 0.88326005 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.88071427 |
| 100 | MP0003755_abnormal_palate_morphology | 0.87924277 |
| 101 | MP0002734_abnormal_mechanical_nocicepti | 0.87874288 |
| 102 | MP0000427_abnormal_hair_cycle | 0.87253379 |
| 103 | MP0002932_abnormal_joint_morphology | 0.86863033 |
| 104 | MP0001756_abnormal_urination | 0.86684859 |
| 105 | MP0003635_abnormal_synaptic_transmissio | 0.86465390 |
| 106 | MP0009780_abnormal_chondrocyte_physiolo | 0.85987678 |
| 107 | MP0004885_abnormal_endolymph | 0.85854206 |
| 108 | MP0000049_abnormal_middle_ear | 0.85403387 |
| 109 | MP0005620_abnormal_muscle_contractility | 0.85332636 |
| 110 | MP0003861_abnormal_nervous_system | 0.85291022 |
| 111 | MP0004085_abnormal_heartbeat | 0.85070074 |
| 112 | MP0002092_abnormal_eye_morphology | 0.84613785 |
| 113 | MP0002128_abnormal_blood_circulation | 0.84593983 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.84524298 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.84332317 |
| 116 | MP0000747_muscle_weakness | 0.84302691 |
| 117 | MP0004145_abnormal_muscle_electrophysio | 0.83559652 |
| 118 | MP0005167_abnormal_blood-brain_barrier | 0.83097405 |
| 119 | MP0009703_decreased_birth_body | 0.82938915 |
| 120 | * MP0002078_abnormal_glucose_homeostasis | 0.82531101 |
| 121 | MP0001286_abnormal_eye_development | 0.81755261 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.81713928 |
| 123 | MP0005670_abnormal_white_adipose | 0.81138156 |
| 124 | MP0000432_abnormal_head_morphology | 0.80257228 |
| 125 | MP0002168_other_aberrant_phenotype | 0.80187698 |
| 126 | MP0002249_abnormal_larynx_morphology | 0.79821690 |
| 127 | MP0005380_embryogenesis_phenotype | 0.79533172 |
| 128 | MP0001672_abnormal_embryogenesis/_devel | 0.79533172 |
| 129 | MP0002152_abnormal_brain_morphology | 0.79159404 |
| 130 | MP0003329_amyloid_beta_deposits | 0.78693044 |
| 131 | MP0000516_abnormal_urinary_system | 0.78136592 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.78136592 |
| 133 | MP0002133_abnormal_respiratory_system | 0.77510318 |
| 134 | MP0005388_respiratory_system_phenotype | 0.77510318 |
| 135 | MP0000749_muscle_degeneration | 0.76855483 |
| 136 | MP0004484_altered_response_of | 0.76731387 |
| 137 | MP0000579_abnormal_nail_morphology | 0.76351663 |
| 138 | MP0002736_abnormal_nociception_after | 0.75874875 |
| 139 | MP0005535_abnormal_body_temperature | 0.74526009 |
| 140 | MP0009764_decreased_sensitivity_to | 0.74507257 |
| 141 | MP0001968_abnormal_touch/_nociception | 0.70015435 |
| 142 | MP0005379_endocrine/exocrine_gland_phen | 0.69678837 |
| 143 | MP0006276_abnormal_autonomic_nervous | 0.68291772 |
| 144 | MP0005503_abnormal_tendon_morphology | 0.67771318 |
| 145 | MP0005451_abnormal_body_composition | 0.66037512 |
| 146 | MP0009642_abnormal_blood_homeostasis | 0.65786696 |
| 147 | MP0005376_homeostasis/metabolism_phenot | 0.64665807 |
| 148 | MP0005408_hypopigmentation | 0.64600930 |
| 149 | MP0003690_abnormal_glial_cell | 0.64402710 |
| 150 | MP0009763_increased_sensitivity_to | 0.64224473 |
| 151 | MP0005636_abnormal_mineral_homeostasis | 0.64220453 |
| 152 | MP0000639_abnormal_adrenal_gland | 0.63420013 |
| 153 | MP0001346_abnormal_lacrimal_gland | 0.63199195 |
| 154 | MP0002896_abnormal_bone_mineralization | 0.62715983 |
| 155 | MP0002295_abnormal_pulmonary_circulatio | 0.59336436 |
| 156 | MP0004883_abnormal_blood_vessel | 0.58930726 |
| 157 | MP0005334_abnormal_fat_pad | 0.57196603 |
| 158 | MP0004270_analgesia | 0.56350222 |
| 159 | MP0003186_abnormal_redox_activity | 0.56039972 |
| 160 | MP0009379_abnormal_foot_pigmentation | 0.55892188 |
| 161 | MP0005448_abnormal_energy_balance | 0.55857025 |
| 162 | MP0003045_fibrosis | 0.55112022 |
| 163 | MP0003279_aneurysm | 0.53372291 |
| 164 | MP0005275_abnormal_skin_tensile | 0.52906039 |
| 165 | MP0000538_abnormal_urinary_bladder | 0.51788962 |
| 166 | MP0001177_atelectasis | 0.50928394 |
| 167 | MP0002971_abnormal_brown_adipose | 0.50921841 |
| 168 | MP0000230_abnormal_systemic_arterial | 0.48266246 |
| 169 | MP0002060_abnormal_skin_morphology | 0.47580410 |
| 170 | MP0002108_abnormal_muscle_morphology | 0.47373343 |
| 171 | MP0005666_abnormal_adipose_tissue | 0.46965275 |
| 172 | MP0005395_other_phenotype | 0.46363110 |
| 173 | MP0008469_abnormal_protein_level | 0.46317450 |
| 174 | MP0009765_abnormal_xenobiotic_induced | 0.45256593 |
| 175 | MP0005248_abnormal_Harderian_gland | 0.43743566 |
| 176 | MP0001299_abnormal_eye_distance/ | 0.43409828 |
| 177 | MP0003724_increased_susceptibility_to | 0.42919167 |
| 178 | MP0003942_abnormal_urinary_system | 0.42433133 |
| 179 | MP0002796_impaired_skin_barrier | 0.41568236 |
| 180 | MP0001986_abnormal_taste_sensitivity | 0.40733633 |
| 181 | MP0001348_abnormal_lacrimal_gland | 0.40138752 |
| 182 | MP0002269_muscular_atrophy | 0.39438258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.79201836 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.56350756 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.35024001 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.74610875 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.74486310 |
| 6 | Xanthomatosis (HP:0000991) | 5.56691117 |
| 7 | Complement deficiency (HP:0004431) | 5.31836837 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.83575226 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.43610445 |
| 10 | Epidermoid cyst (HP:0200040) | 4.05646707 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.05542462 |
| 12 | Hyperammonemia (HP:0001987) | 4.04517373 |
| 13 | Joint hemorrhage (HP:0005261) | 4.01688877 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.00813663 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 3.96318058 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 3.91141856 |
| 17 | Hypoglycemic coma (HP:0001325) | 3.86791053 |
| 18 | Ketosis (HP:0001946) | 3.86635040 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.85475561 |
| 20 | Abnormality of complement system (HP:0005339) | 3.82855672 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.82704895 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.71974825 |
| 23 | Hyperglycinemia (HP:0002154) | 3.71869310 |
| 24 | Fat malabsorption (HP:0002630) | 3.68965872 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67604859 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.59572247 |
| 27 | Hyperglycinuria (HP:0003108) | 3.41410946 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.41038739 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.33363119 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.33363119 |
| 31 | Ketoacidosis (HP:0001993) | 3.00522505 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.96475802 |
| 33 | Skin nodule (HP:0200036) | 2.92696408 |
| 34 | Arterial tortuosity (HP:0005116) | 2.91871741 |
| 35 | Spontaneous abortion (HP:0005268) | 2.87532868 |
| 36 | Cutaneous syndactyly (HP:0012725) | 2.86828656 |
| 37 | Vascular tortuosity (HP:0004948) | 2.86032118 |
| 38 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.85902981 |
| 39 | Hypercholesterolemia (HP:0003124) | 2.81275120 |
| 40 | Myocardial infarction (HP:0001658) | 2.78486786 |
| 41 | Hyperbilirubinemia (HP:0002904) | 2.77662009 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.76195037 |
| 43 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.71676900 |
| 44 | Aplasia of the phalanges of the hand (HP:0009802) | 2.71676900 |
| 45 | Aplasia involving bones of the extremities (HP:0009825) | 2.71676900 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.70192665 |
| 47 | Absent eyelashes (HP:0000561) | 2.68056259 |
| 48 | Steatorrhea (HP:0002570) | 2.66637690 |
| 49 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.65307699 |
| 50 | Hypoglycemic seizures (HP:0002173) | 2.61637340 |
| 51 | Abnormality of serum amino acid levels (HP:0003112) | 2.56677663 |
| 52 | Hepatocellular carcinoma (HP:0001402) | 2.55308118 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.52732090 |
| 54 | Hypoplasia of the iris (HP:0007676) | 2.51754329 |
| 55 | Hypophosphatemic rickets (HP:0004912) | 2.49842716 |
| 56 | Gout (HP:0001997) | 2.48155353 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.46444285 |
| 58 | Wide anterior fontanel (HP:0000260) | 2.45838449 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.45798825 |
| 60 | Glomerulonephritis (HP:0000099) | 2.41549849 |
| 61 | Mitral stenosis (HP:0001718) | 2.36877400 |
| 62 | Neonatal short-limb short stature (HP:0008921) | 2.34896892 |
| 63 | Absent eyebrow (HP:0002223) | 2.27155167 |
| 64 | Vertebral arch anomaly (HP:0008438) | 2.23486964 |
| 65 | Aortic dissection (HP:0002647) | 2.23091810 |
| 66 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.22797968 |
| 67 | Limited hip movement (HP:0008800) | 2.22408844 |
| 68 | Metabolic acidosis (HP:0001942) | 2.21250884 |
| 69 | Coronal craniosynostosis (HP:0004440) | 2.20529598 |
| 70 | Midline defect of the nose (HP:0004122) | 2.20371783 |
| 71 | Shallow orbits (HP:0000586) | 2.19877225 |
| 72 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.19613707 |
| 73 | Short 4th metacarpal (HP:0010044) | 2.19613707 |
| 74 | Neonatal onset (HP:0003623) | 2.19102136 |
| 75 | Vascular calcification (HP:0004934) | 2.18801960 |
| 76 | Premature rupture of membranes (HP:0001788) | 2.17989504 |
| 77 | Action tremor (HP:0002345) | 2.13031086 |
| 78 | Enlarged kidneys (HP:0000105) | 2.12067122 |
| 79 | Dicarboxylic aciduria (HP:0003215) | 2.11494518 |
| 80 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11494518 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 2.10172686 |
| 82 | Hyperglycemia (HP:0003074) | 2.09950066 |
| 83 | Rickets (HP:0002748) | 2.09092178 |
| 84 | Bell-shaped thorax (HP:0001591) | 2.09075002 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.07595002 |
| 86 | Myelomeningocele (HP:0002475) | 2.07191464 |
| 87 | Papillary thyroid carcinoma (HP:0002895) | 2.07176618 |
| 88 | Morphological abnormality of the middle ear (HP:0008609) | 2.06843678 |
| 89 | Lethargy (HP:0001254) | 2.06072347 |
| 90 | Irritability (HP:0000737) | 2.05479883 |
| 91 | Esophageal varix (HP:0002040) | 2.01542909 |
| 92 | Preaxial foot polydactyly (HP:0001841) | 2.01056289 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 1.99398823 |
| 94 | Abnormality of proline metabolism (HP:0010907) | 1.98454438 |
| 95 | Hydroxyprolinuria (HP:0003080) | 1.98454438 |
| 96 | Overgrowth (HP:0001548) | 1.97266913 |
| 97 | Aortic aneurysm (HP:0004942) | 1.97249040 |
| 98 | Proximal tubulopathy (HP:0000114) | 1.97203103 |
| 99 | Ulnar bowing (HP:0003031) | 1.96977716 |
| 100 | Hepatoblastoma (HP:0002884) | 1.96674839 |
| 101 | Cerebral aneurysm (HP:0004944) | 1.96193026 |
| 102 | Amyloidosis (HP:0011034) | 1.94767753 |
| 103 | Acanthocytosis (HP:0001927) | 1.93730515 |
| 104 | Protrusio acetabuli (HP:0003179) | 1.92069452 |
| 105 | Cholelithiasis (HP:0001081) | 1.91912802 |
| 106 | Bilateral microphthalmos (HP:0007633) | 1.88660099 |
| 107 | Pancreatitis (HP:0001733) | 1.87717239 |
| 108 | Abnormality of the 4th metacarpal (HP:0010012) | 1.85747966 |
| 109 | Missing ribs (HP:0000921) | 1.85458721 |
| 110 | Turricephaly (HP:0000262) | 1.84378265 |
| 111 | Pulmonic stenosis (HP:0001642) | 1.84132489 |
| 112 | Difficulty running (HP:0009046) | 1.83074684 |
| 113 | Soft skin (HP:0000977) | 1.82308249 |
| 114 | Late onset (HP:0003584) | 1.81569523 |
| 115 | Symptomatic seizures (HP:0011145) | 1.81128265 |
| 116 | Nephritis (HP:0000123) | 1.81089532 |
| 117 | Hammertoe (HP:0001765) | 1.80450472 |
| 118 | Mitral valve prolapse (HP:0001634) | 1.80044100 |
| 119 | Abnormality of the lacrimal duct (HP:0011481) | 1.78490496 |
| 120 | Abnormal cartilage morphology (HP:0002763) | 1.78395381 |
| 121 | Generalized aminoaciduria (HP:0002909) | 1.78149463 |
| 122 | Malnutrition (HP:0004395) | 1.77802304 |
| 123 | Right ventricular cardiomyopathy (HP:0011663) | 1.77635086 |
| 124 | Mild short stature (HP:0003502) | 1.77522191 |
| 125 | Cerebral edema (HP:0002181) | 1.77408388 |
| 126 | Alacrima (HP:0000522) | 1.76632297 |
| 127 | Absent hair (HP:0002298) | 1.75117695 |
| 128 | Renal hypoplasia (HP:0000089) | 1.75057699 |
| 129 | Abnormality of the pubic bones (HP:0003172) | 1.74811423 |
| 130 | Exercise-induced muscle cramps (HP:0003710) | 1.74614886 |
| 131 | Decreased lacrimation (HP:0000633) | 1.74336919 |
| 132 | Omphalocele (HP:0001539) | 1.73230120 |
| 133 | Cerebellar dysplasia (HP:0007033) | 1.72965547 |
| 134 | Bronchomalacia (HP:0002780) | 1.72904416 |
| 135 | Fibular hypoplasia (HP:0003038) | 1.72047879 |
| 136 | Abnormal auditory evoked potentials (HP:0006958) | 1.71813780 |
| 137 | Clitoromegaly (HP:0000057) | 1.71233488 |
| 138 | Thickened helices (HP:0000391) | 1.71103178 |
| 139 | Protuberant abdomen (HP:0001538) | 1.70739104 |
| 140 | Calcaneovalgus deformity (HP:0001848) | 1.70268914 |
| 141 | Cortical dysplasia (HP:0002539) | 1.69577897 |
| 142 | Choanal stenosis (HP:0000452) | 1.68888301 |
| 143 | Opisthotonus (HP:0002179) | 1.68699939 |
| 144 | Cutaneous finger syndactyly (HP:0010554) | 1.66663005 |
| 145 | Menorrhagia (HP:0000132) | 1.66191809 |
| 146 | Periauricular skin pits (HP:0100277) | 1.66167792 |
| 147 | Preauricular pit (HP:0004467) | 1.66167792 |
| 148 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.65615446 |
| 149 | Pigmentary retinal degeneration (HP:0001146) | 1.65072547 |
| 150 | Renal cortical cysts (HP:0000803) | 1.64890870 |
| 151 | Spastic diplegia (HP:0001264) | 1.64699047 |
| 152 | Hyporeflexia of lower limbs (HP:0002600) | 1.63166663 |
| 153 | Bifid tongue (HP:0010297) | 1.63137915 |
| 154 | Wormian bones (HP:0002645) | 1.62810677 |
| 155 | Atrophic scars (HP:0001075) | 1.62673648 |
| 156 | Megalencephaly (HP:0001355) | 1.62361270 |
| 157 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.62053491 |
| 158 | Scanning speech (HP:0002168) | 1.61057663 |
| 159 | Blue irides (HP:0000635) | 1.60467566 |
| 160 | Vertebral clefting (HP:0008428) | 1.59109323 |
| 161 | Pheochromocytoma (HP:0002666) | 1.58717915 |
| 162 | Tracheomalacia (HP:0002779) | 1.58597603 |
| 163 | Anophthalmia (HP:0000528) | 1.57450861 |
| 164 | Ectopic anus (HP:0004397) | 1.57183566 |
| 165 | Hypoplastic ischia (HP:0003175) | 1.56354456 |
| 166 | * Abnormality of the ischium (HP:0003174) | 1.56354456 |
| 167 | Aqueductal stenosis (HP:0002410) | 1.56234614 |
| 168 | Visceral angiomatosis (HP:0100761) | 1.56078253 |
| 169 | Hyperventilation (HP:0002883) | 1.55269502 |
| 170 | Congenital malformation of the right heart (HP:0011723) | 1.54926426 |
| 171 | Double outlet right ventricle (HP:0001719) | 1.54926426 |
| 172 | Abnormality of dentin (HP:0010299) | 1.51395760 |
| 173 | Bladder diverticulum (HP:0000015) | 1.51352460 |
| 174 | Arnold-Chiari malformation (HP:0002308) | 1.50739327 |
| 175 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.50179212 |
| 176 | Hemangiomatosis (HP:0007461) | 1.48928195 |
| 177 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.48776976 |
| 178 | Anal stenosis (HP:0002025) | 1.48582646 |
| 179 | Volvulus (HP:0002580) | 1.47182781 |
| 180 | Vitreoretinal degeneration (HP:0000655) | 1.46619494 |
| 181 | Distal arthrogryposis (HP:0005684) | 1.45757145 |
| 182 | Neoplasm of the heart (HP:0100544) | 1.45606949 |
| 183 | Split foot (HP:0001839) | 1.45288981 |
| 184 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.45246999 |
| 185 | Subaortic stenosis (HP:0001682) | 1.45246999 |
| 186 | Cubitus valgus (HP:0002967) | 1.45183014 |
| 187 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.43524943 |
| 188 | Shawl scrotum (HP:0000049) | 1.42978827 |
| 189 | Hemiparesis (HP:0001269) | 1.42777788 |
| 190 | Long clavicles (HP:0000890) | 1.42488387 |
| 191 | Broad metatarsal (HP:0001783) | 1.42087730 |
| 192 | Abnormality of the calf musculature (HP:0001430) | 1.41876136 |
| 193 | Abnormal pancreas size (HP:0012094) | 1.41583123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.82412875 |
| 2 | SIK1 | 3.45246342 |
| 3 | FGFR4 | 3.12460771 |
| 4 | INSRR | 2.89723104 |
| 5 | FRK | 2.70243900 |
| 6 | TNIK | 2.63273754 |
| 7 | MARK1 | 2.55122774 |
| 8 | FGFR2 | 2.48853152 |
| 9 | OBSCN | 2.41862938 |
| 10 | ERN1 | 2.32282852 |
| 11 | FER | 2.27777257 |
| 12 | EPHA3 | 2.00069812 |
| 13 | PNCK | 1.96672109 |
| 14 | BCR | 1.95603099 |
| 15 | CASK | 1.92577479 |
| 16 | ERBB4 | 1.85208811 |
| 17 | NTRK2 | 1.83784820 |
| 18 | SGK2 | 1.76413745 |
| 19 | STK39 | 1.73950921 |
| 20 | NTRK1 | 1.73362923 |
| 21 | SGK494 | 1.64158883 |
| 22 | SGK223 | 1.64158883 |
| 23 | PBK | 1.61737346 |
| 24 | PRKD3 | 1.60579531 |
| 25 | DAPK2 | 1.60068036 |
| 26 | STK38L | 1.52997720 |
| 27 | MAPK15 | 1.51892610 |
| 28 | MAP2K4 | 1.50291744 |
| 29 | NEK9 | 1.44854349 |
| 30 | SGK3 | 1.44630784 |
| 31 | FGFR3 | 1.43423091 |
| 32 | RIPK1 | 1.39029231 |
| 33 | MAP3K2 | 1.29650110 |
| 34 | TIE1 | 1.28186005 |
| 35 | TYK2 | 1.26425316 |
| 36 | EPHB1 | 1.25933205 |
| 37 | BRD4 | 1.25227826 |
| 38 | PDGFRB | 1.24821325 |
| 39 | TTN | 1.16632875 |
| 40 | JAK1 | 1.16627935 |
| 41 | LATS1 | 1.15770824 |
| 42 | LMTK2 | 1.15177159 |
| 43 | TAOK3 | 1.13988113 |
| 44 | EPHB2 | 1.11526817 |
| 45 | MAP2K1 | 1.11416666 |
| 46 | CAMK1D | 1.10872248 |
| 47 | ERBB3 | 1.09327264 |
| 48 | MINK1 | 1.07808042 |
| 49 | MST1R | 1.05589191 |
| 50 | PIK3CG | 1.02179116 |
| 51 | PTK6 | 1.00577807 |
| 52 | TYRO3 | 0.99862025 |
| 53 | MAPK11 | 0.98595278 |
| 54 | AKT3 | 0.97065063 |
| 55 | JAK2 | 0.97058110 |
| 56 | NTRK3 | 0.97014977 |
| 57 | PAK3 | 0.95835285 |
| 58 | MAP3K7 | 0.95076455 |
| 59 | EEF2K | 0.94979156 |
| 60 | MKNK2 | 0.94878158 |
| 61 | PKN2 | 0.94852580 |
| 62 | TSSK6 | 0.93391124 |
| 63 | FLT3 | 0.93024498 |
| 64 | RET | 0.92778859 |
| 65 | BMPR1B | 0.92447164 |
| 66 | NEK6 | 0.90311893 |
| 67 | PRKAA2 | 0.87912339 |
| 68 | MAP3K14 | 0.87729715 |
| 69 | MET | 0.87353184 |
| 70 | PRKCH | 0.87174199 |
| 71 | DMPK | 0.85752918 |
| 72 | PAK6 | 0.84523736 |
| 73 | ROCK2 | 0.83824961 |
| 74 | PINK1 | 0.83481867 |
| 75 | ICK | 0.82027639 |
| 76 | WNK3 | 0.81668726 |
| 77 | EPHA4 | 0.79530480 |
| 78 | WEE1 | 0.79209014 |
| 79 | LATS2 | 0.78332587 |
| 80 | ACVR1B | 0.77499496 |
| 81 | ERBB2 | 0.76325975 |
| 82 | PDGFRA | 0.76310768 |
| 83 | PTK2 | 0.76284684 |
| 84 | WNK4 | 0.75022997 |
| 85 | DDR2 | 0.74214751 |
| 86 | PRKAA1 | 0.74099669 |
| 87 | PHKG2 | 0.74043265 |
| 88 | PHKG1 | 0.74043265 |
| 89 | KSR1 | 0.72575544 |
| 90 | GSK3A | 0.72234659 |
| 91 | PRKCZ | 0.71761392 |
| 92 | TGFBR2 | 0.70325851 |
| 93 | KSR2 | 0.68753206 |
| 94 | YES1 | 0.68022989 |
| 95 | MAP3K10 | 0.67553413 |
| 96 | CAMK2B | 0.67415297 |
| 97 | PRKCG | 0.67007042 |
| 98 | PRKACG | 0.65877543 |
| 99 | MOS | 0.64179644 |
| 100 | MKNK1 | 0.63892919 |
| 101 | TRIB3 | 0.63204353 |
| 102 | PAK2 | 0.62451989 |
| 103 | * MAPK10 | 0.62220135 |
| 104 | CDC42BPA | 0.62026467 |
| 105 | CAMK2G | 0.61764552 |
| 106 | NLK | 0.61092307 |
| 107 | PLK2 | 0.59371223 |
| 108 | CAMK2D | 0.57975824 |
| 109 | SIK3 | 0.57677058 |
| 110 | IGF1R | 0.57588404 |
| 111 | OXSR1 | 0.57562147 |
| 112 | KDR | 0.57439594 |
| 113 | RPS6KA2 | 0.57290728 |
| 114 | PDK2 | 0.56525431 |
| 115 | FGFR1 | 0.55431951 |
| 116 | RPS6KB1 | 0.53383255 |
| 117 | PRKCE | 0.52785577 |
| 118 | PDPK1 | 0.52474468 |
| 119 | CAMK1G | 0.51321634 |
| 120 | PKN1 | 0.50886386 |
| 121 | CAMK2A | 0.50812056 |
| 122 | IRAK1 | 0.50776822 |
| 123 | MAPK12 | 0.50771945 |
| 124 | CAMK4 | 0.50695207 |
| 125 | CDK5 | 0.50681444 |
| 126 | STK3 | 0.50646659 |
| 127 | MAP3K3 | 0.49982382 |
| 128 | ADRBK1 | 0.49842712 |
| 129 | PLK4 | 0.49518279 |
| 130 | BRSK2 | 0.49491941 |
| 131 | MELK | 0.48228255 |
| 132 | PIK3CA | 0.47994031 |
| 133 | SCYL2 | 0.47260517 |
| 134 | GRK5 | 0.47199546 |
| 135 | CSNK1G2 | 0.47173708 |
| 136 | CSNK1G1 | 0.46940499 |
| 137 | UHMK1 | 0.46390929 |
| 138 | MAPK13 | 0.45243271 |
| 139 | MAP2K7 | 0.45111368 |
| 140 | ROCK1 | 0.44326449 |
| 141 | MAPK7 | 0.43362301 |
| 142 | NEK2 | 0.43317265 |
| 143 | TGFBR1 | 0.43019687 |
| 144 | MAP3K1 | 0.40872978 |
| 145 | MAP3K4 | 0.39921610 |
| 146 | MAPKAPK3 | 0.39843416 |
| 147 | PRKACB | 0.39738564 |
| 148 | MATK | 0.38975265 |
| 149 | PRKD1 | 0.38548889 |
| 150 | PDK4 | 0.34307046 |
| 151 | PDK3 | 0.34307046 |
| 152 | MTOR | 0.34015311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.27240754 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.61776809 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27805129 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.90838020 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.79655486 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79104991 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.67889103 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64980758 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59453073 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.49713229 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.46701041 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19862058 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09364914 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06286789 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.05515756 |
| 16 | Adherens junction_Homo sapiens_hsa04520 | 2.05456372 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03165674 |
| 18 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.94941759 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94739143 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85096895 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83568245 |
| 22 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.79504906 |
| 23 | Focal adhesion_Homo sapiens_hsa04510 | 1.74549431 |
| 24 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.73845143 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.73357421 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70438395 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.69408832 |
| 28 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.69083735 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66596553 |
| 30 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.65025978 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63085818 |
| 32 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.62787457 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61708272 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59346459 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.56555778 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.56418892 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56276129 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.54822982 |
| 39 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.50129088 |
| 40 | Axon guidance_Homo sapiens_hsa04360 | 1.48214457 |
| 41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.45763279 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.44897908 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 1.44011447 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43440854 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.42566003 |
| 46 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.41839287 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.41770712 |
| 48 | Tight junction_Homo sapiens_hsa04530 | 1.38373547 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.37637719 |
| 50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37199401 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36591834 |
| 52 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.35205201 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.34349520 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32849469 |
| 55 | Melanogenesis_Homo sapiens_hsa04916 | 1.31039897 |
| 56 | * Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.30518691 |
| 57 | Long-term potentiation_Homo sapiens_hsa04720 | 1.29854520 |
| 58 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.28840049 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28574901 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.28215366 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 1.27656189 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24597528 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22832546 |
| 64 | Gap junction_Homo sapiens_hsa04540 | 1.22663882 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.21828594 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.20096531 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.19266225 |
| 68 | Renin secretion_Homo sapiens_hsa04924 | 1.18237293 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16465386 |
| 70 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.16078797 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.14564717 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.13309319 |
| 73 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11189426 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10709420 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09291520 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.06844233 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.03685804 |
| 78 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.03510759 |
| 79 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.03282060 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 1.02179077 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 1.01096564 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.00754797 |
| 83 | Glioma_Homo sapiens_hsa05214 | 1.00455063 |
| 84 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.97624213 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.97065239 |
| 86 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.96708651 |
| 87 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.96687295 |
| 88 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96366208 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95578531 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94799529 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94616047 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93621228 |
| 93 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90783100 |
| 94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.90187377 |
| 95 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.90145204 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89909749 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88244495 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88120428 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87336232 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.86390269 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85771066 |
| 102 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84491619 |
| 103 | Pathways in cancer_Homo sapiens_hsa05200 | 0.83958139 |
| 104 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83373784 |
| 105 | Salivary secretion_Homo sapiens_hsa04970 | 0.80494926 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80403301 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79122204 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.77274367 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76379671 |
| 110 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75645073 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75452022 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.74569761 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73087184 |
| 114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70095608 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69749488 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63824295 |
| 117 | Taste transduction_Homo sapiens_hsa04742 | 0.63047399 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61467180 |
| 119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61133975 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.60772413 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59663759 |
| 122 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58498833 |
| 123 | Alcoholism_Homo sapiens_hsa05034 | 0.57542736 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.57253175 |
| 125 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56048323 |
| 126 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55111987 |
| 127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54409874 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.54018129 |
| 129 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52678533 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51749035 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46419789 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.44504099 |
| 133 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39214880 |
| 134 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33689461 |
| 135 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32245719 |
| 136 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30872980 |
| 137 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.24407744 |
| 138 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22339678 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20050698 |
| 140 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19572946 |
| 141 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.18538069 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14454786 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13970875 |
| 144 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13011644 |
| 145 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.11379893 |
| 146 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.10460942 |
| 147 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09191666 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.08940168 |
| 149 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08464899 |
| 150 | Galactose metabolism_Homo sapiens_hsa00052 | 0.08215855 |
| 151 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.07923851 |
| 152 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.07161218 |
| 153 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.06320956 |
| 154 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.05359962 |
| 155 | Insulin secretion_Homo sapiens_hsa04911 | 0.03155920 |
| 156 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02202124 |
| 157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.01234925 |
| 158 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.00794796 |
| 159 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.00140485 |
| 160 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.00078190 |
| 161 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0586256 |
| 162 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0580882 |
| 163 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0498802 |
| 164 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | -0.0485801 |
| 165 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | -0.0480219 |
| 166 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0395220 |
| 167 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0027441 |
| 168 | Amoebiasis_Homo sapiens_hsa05146 | -0.0003115 |

